Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer

Journal of Clinical Oncology

Volumn 14, Issue 8, 1996, Pages 2322-2330

  Eisbruch, A ^a   Thornton, A F ^a   Urba, S ^a   Esclamado, R M ^a   Carroll, W R ^a   Bradford, C R ^a   Hazuka, M B ^a   Littles, F J ^a   Strawderman, M ^a   Wolf, G T ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; EPIGLOTTIS; EROSION; FEMALE; HEARING LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARYNGECTOMY; LARYNX CANCER; LARYNX EDEMA; MALE; MUCOSA INFLAMMATION; ORGAN PRESERVATION; PERIPHERAL NEUROPATHY; PHARYNX DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; TREATMENT FAILURE;

EID: 9444280129     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.8.2322     Document Type: Article

References (48)

1. Yuen A, Medina JE, Goepfert H: Management of stage T3 and T4 glottic carcinoma. Am J Surg 148:467-472, 1984
2. Harwood AR, Hawkins NV, Beale FA, et al: Management of advanced glottic cancer. A 10 year review of the Toronto experience. Int J Radiat Oncol Biol Phys 5:899-904, 1979
3. Croll GA, Gerritsen GJ, Tiwari RM, et al: Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma. Eur J Surg Oncol 15:350-356, 1989
4. Mendenhall WM, Parsons JT, Stringer SP, et al: Stage T3 squamous cell carcinoma of the glottic larynx: A comparison of laryngectomy and irradiation. Int J Radiat Oncol Biol Phys 23:725-732, 1992
5. Kazem I, van den Broek P: Planned preoperative radiation therapy vs. definitive radiotherapy for advanced laryngeal carcinoma. Laryngoscope 94:1355-1358, 1984
6. Ensley JF, Jacobs JR, Weaver A: Correlation between response of cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54:811-814, 1984
7. Hong WK, O'Donoghue GM, Sheetz S: Sequential response pattern to chemotherapy and radiotherapy in head and neck cancer: Potential impact of treatment in advanced laryngeal cancer, in Wagener DJT, Blijham A, Smeets JBE, et al (eds): Primary Chemotherapy in Cancer Medicine (vol 201 of Progress in Clinical and Biological Research). New York, NY, Alan Riss, 1985, pp 191-197
8. Demard F, Chauvel P, Santini J, et al: Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Head Neck 12:225-231, 1990
9. Jacobs C, Goffinet DR, Goffinet L, et al: Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. Cancer 60:1178-1183, 1987
10. Karp DD, Vaughan CW, Carter R, et al: Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. Am J Clin Oncol 14:273-279, 1991
11. Busse PM, Clark JR, Beard CJ, et al: Primary site management following induction chemotherapy with cis-platinum, 5-fluorouracil, and leucovorin. Head Neck 15:413-418, 1993
12. Pfister DG, Strong E, Harrison L, et al: Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 9:850-859, 1991
13. Shirinian MH, Weber RS, Lippman SM, et al: Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: The M.D. Anderson Cancer Center experience. Head Neck 16:39-44, 1994
14. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
15. Withers HR, Taylor HR, Taylor JMG, et al: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131-141, 1988
16. Stephens TC, Steel GG: Regeneration of tumors after cytoxic treatment, in Meyn RE, Withers HR (eds): Radiation Biology in Cancer Research. New York, NY, Raven, 1980, pp 385-393
17. Bourhis J, Wilson G, Wibault P, et al: Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer. Laryngoscope 104:468-472, 1994
18. Wang CC, Blitzer PH, Suit HD: Twice-a-day radiation therapy for cancer of the head and neck. Cancer 55:2100-2104, 1985
19. Ang KK, Peters LJ, Weber RS, et al: Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 19:1339-1345, 1990
20. Schmidt-Ullrich RK, Johnson CR, Wazer DE, et al: Accelerated superfractionated irradiation for advanced carcinoma of the head and neck: Concomitant boost technique. Am J Radial Oncol Biol Phys 21:563-568, 1991
21. Begg AC, Hofland I, Van Glabekke M, et al: Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851. Semin Radiat Oncol 2:22-25, 1992
22. Kaplan EL, Meier P: Nonparametric estimate from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135:185-198, 1972
24. Fleiss JL: Assessing significance in a four fold table, in Statistical Methods for Rates and Proportions. New York, NY, Wiley, 1973, pp 24-26
25. Stell PM: Adjuvant chemotherapy in head and neck cancer. Semin Radiat Oncol 2:195-205, 1992
26. Munro AJ: An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83-91, 1995
27. Pfister DG, Harrison LB, Strong EW, et al: Organ-function preservation in advanced oropharynx cancer: Results with induction chemotherapy and radiation. J Clin Oncol 13:671-680, 1995
28. Spaulding MB, Fischer SG, Wolf T, et al: Tumor response, toxicity and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 12:1592-1599, 1994
29. Beauduin VGM, Humblet Y, Hamoir M, et al: A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: A report from the UCL-Oncology Group, Belgium. J Clin Oncol 9:1385-1392, 1991
30. Urba SG, Forastiere AA, Wolf GT, et al: Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol 12:946-953, 1994
31. Pfister DG, Bajorin D, Motzer R, et al: Cisplatin. fluorouracil and leucovorin: Increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 120:89-95, 1994
32. Vokes EE, Weichselbaum RR, Mick R, et al: Favorable long-term survival following induction chemotherapy with cisplatin. fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 84:877-882, 1992
33. Vokes EE, Kies M, Mick R, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 13:876-883, 1995
34. Bujko K, Skoczylas JZ, Bentzen SM, et al: A feasibility study of concomitant boost radiotherapy for patients with cancer of the supraglottic larynx. Acta Oncologica 32:637-640, 1993
35. Kaanders JHA, van Daal WAJ, Hoogenraad WJ, et al: Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity. Int J Radiat Oncol Biol Phys 24:497-503, 1992
36. Fu KK, Clery M, Ang KK, et al: Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: Results of RTOG-8809. Int J Radiat Oncol Biol Phys 32:589-598, 1995
37. Lee D-J, Cosmatos D, Marcial VA, et al: Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys 32:567-576, 1995
38. Panje WR, Namon AJ, Vokes E, et al: Surgical management of the head and neck cancer patient following concomitant multimodality therapy. Laryngoscope 105:97-101, 1995
39. Parsons JT, Mendenhall WM, Stringer SP, et al: Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys 32:605-609, 1995
40. Terhaard CHJ, Karim ABMF, Hoogenraad WJ, et al: Local control in T3 laryngeal cancer treated with radical radiotherapy, time dose relationship: The concept of nominal standard dose and linear quadratic model. Int J Radiat Oncol Biol Phys 20:1207-1214, 1991
41. Schuller DE, Meten B, Stein DW: Preoperative chemotherapy in advanced resectable head and neck cancer - Final report of the Southwest Oncology Group. Laryngoscope 98:1205-1211, 1988
42. Delong PC, Stroben WH: Pharyngeal fistula after laryngectomy. J Laryngol Otol 34:897-903, 1970
43. Peters LJ, Ang KK, Thames HD: Accelerated fractionation in the radiation treatment of head and neck cancer. Acta Oncologica 27:185-194, 1988
44. Pfister D, Harrison L, Kraus D, et al: Larynx preservation (LP): Does induction cisplatin (C)-based chemotherapy (CT) compromise the delivery of concomitant C with radiation therapy (RT)? Proc Am Soc Clin Oncol 13:292, 1994 (abstr)
45. Taylor SG, Murthy AK, Vannetzel J-M, et al: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12:385-395, 1994
46. An interim report from the SECOG participants: A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 12:289-295, 1986
47. Gregg CM, Beals TE, McClatchey KM: DNA content and tumor response to induction chemotherapy in patients with advanced laryngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 108:731-737, 1993
48. Bradford CR, Zhu S, Wolf GT: Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Otolaryngol Head Neck Surg 113:408-412, 1995